Trial Profile
Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: AF Suppression Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2016
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary) ; Amlodipine
- Indications Atrial fibrillation; Hypertension
- Focus Therapeutic Use
- Acronyms SILK
- 10 Jun 2016 Status changed from recruiting to completed.
- 19 Aug 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 17 Mar 2011 New trial record